[Asfotase alfa (hypophosphatasia) - Benefit assessment according to §35a Social Code Book V]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003637
German
Original Title: Asfotase alfa (Hypophosphatasie)
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/a19-89.html
Year Published: 2020
URL for published report: https://www.iqwig.de/download/A19-89_Asfotase-alfa_Nutzenbewertung-35a-SGB-V_V1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Hypophosphatasia
  • Alkaline Phosphatase
  • Immunoglobulin G
  • Recombinant Fusion Proteins
  • Enzyme Replacement Therapy
Keywords
  • Asfotase alfa
  • Hypophosphatasia
  • Benefit Assessment
  • NCT00744042
  • NCT01205152
  • NCT01176266
  • NCT01419028
  • NCT01163149
  • NCT00952484
  • NCT01203826
  • NCT02104219
  • NCT02235493
  • NCT03418389
  • NCT02306720
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.